PAD isozyme specific regulation and application of PAD isozyme specific inhibitors (PAD2, PAD3 and PAD4 specific ones) have also been applied in CNS injury models in vitro (brain cancer) [17,18]. The gene discussed is PADI2; the disease is brain cancer.